A CLINICAL TRIAL ON A SIDDHA FORMULATION IN TREATING ANAEMIA(VELUPPU NOI)

EVALUATION OF AYABRINGARAJA PAANIDHAM IN THE MANAGEMENT OF VELUPPU NOI (ANAEMIA)

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2014/07/004802

Enrollment

Registered

2014-07-31

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Iron deficiency anaemia (Veluppu noi)

Interventions

Intervention1: Ayabringaraja Paanidham: Siddha Herbo-Mineral drug. Dosage:2g orally, twice daily for 45 days Control Intervention1: NA: NA

Eligibility

Inclusion criteria

Inclusion criteria: Classical symptoms of Veluppu noi (Pallor, breathlessness on exertion, fatigue, tachycardia) Blood parameters Hb 7-10 g/dl MCV MCHC Serum iron concentration Serum Ferritin

Exclusion criteria

Exclusion criteria: Pregnant and lactating woman Any abnormality in the Blood Platelet count Bleeding disorders, Sickle cell Anaemia and structural anomalies of RBC Cardiac disorders, cancer, renal failure and other major ailments

Design outcomes

Secondary

Measure	Time frame
to evaluate the clinical safety of the ABPTimepoint: 3 months	—

Primary

Measure	Time frame
1.To evaluate the pharmacological activity (Safety and efficacy) of the traditionally prepared ABP 2.To evaluate the clinical efficacy of the ABPTimepoint: 6 weeks	—

Countries

India

Contacts

Public ContactDr V Vijaya Kumar

National Institute of Siddha, Chennai

nisdrloga@yahoo.co.in9444362069

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026